(Total Views: 196)
Posted On: 10/11/2022 8:30:55 AM
Post# of 85377
$SAN News Article - Dupixent (dupilumab) Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis (EoE) in Children 1 to 11 Years Old https://marketwirenews.com/news-releases/dupi...56452.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
